Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Clasificación en acciones #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Precio por acción
$0.0048
Última sincronización: 2023-05-23
Capitalización bursátil
$132.48K
Cambio (1 día)
-20.00%
Cambio (1 año)
0.00%
País
US
Comercio Pear Therapeutics, Inc. (PEAR)

Categoría

Ratio P/S de Pear Therapeutics, Inc. (PEAR)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Pear Therapeutics, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Pear Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras